hotspot -WSS

hotspot

author：entertainment 2025-09-27 12:43:14 - browse：865

LONDON — An experimental blood cancer drug from MorphoSys hit its primary target in a pivotal trial, the company announced late Monday, but the drug faltered in addressing patient symptoms, causing the company’s stock to fall in early Tuesday trading.

In the Phase 3 trial, the German company was testing its drug candidate pelabresib combined with the drug Jakafi against a Jakafi-placebo duo in patients with newly diagnosed myelofibrosis, a type of rare blood cancer. Jakafi is a standard myelofibrosis treatment.

The drug combination succeeded on its primary endpoint, with 66% of patients seeing at least a 35% reduction in spleen volume after 24 weeks versus 35% on the placebo regimen — an improvement the company in a release called “statistically significant and clinically meaningful.” Myelofibrosis is a rare bone marrow cancer that causes low blood cell counts and enlarged spleens, so reducing spleen volume is commonly used as the primary efficacy goal in clinical trials.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： Stroke deaths set to near 10 million globally by 2050

hotspot

WSS

Wegovy improves function in certain heart failure patients

Senate panel eyes new effort on drug shortages

Chemotherapy drug shortage eases slightly but still widespread

In $4.8 billion deal, Bristol Myers Squibb to buy cancer player Mirati

Abortion policy in the spotlight at Republican debate

Histogen: Failed biotech offers rare public look inside

knowledge

hotspot

focus

The cancer drug shortage isn’t new — and neither are the solutions

AI can decode, harness the power of the humane immune system

Novavax promises a turnaround & Lilly roils the obesity market

What past blockbusters can tell us about future of Wegovy and other weight loss medicines

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Meadows told special counsel he could not recall Trump ever declassifying Mar

The cancer drug shortage isn’t new — and neither are the solutions

California store owner shot dead in dispute over displaying Pride flag: Police

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Physician executives need more than on

hotspot

Intellia plays down concerns on accidental germline transmission

A Q&A with the global head of Boehringer Ingelheim's innovation unit

Hospital at home shows how to bring innovation to health care

Roche's accidental data boosts hopes for anti

DeSantis wants to import drugs. Biden’s FDA blasted his plan

VC firm General Catalyst wants to buy a health system

hotspot

hotspot

knowledge

leisure time